Suppr超能文献

相似文献

1
Phenotyping Pain in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
J Clin Endocrinol Metab. 2024 Feb 20;109(3):771-782. doi: 10.1210/clinem/dgad589.
2
Neuropathic-like Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2258-e2266. doi: 10.1210/clinem/dgac120.
4
Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
Orphanet J Rare Dis. 2024 Feb 7;19(1):50. doi: 10.1186/s13023-024-03036-w.
5
Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
Bone. 2023 Jun;171:116744. doi: 10.1016/j.bone.2023.116744. Epub 2023 Mar 21.
6
Expression of RANKL in breast cancer tissue in patients with fibrous dysplasia/McCune-Albright syndrome.
Bone. 2023 Apr;169:116679. doi: 10.1016/j.bone.2023.116679. Epub 2023 Jan 15.
7
Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
Int J Mol Sci. 2023 Jan 29;24(3):2550. doi: 10.3390/ijms24032550.
8
Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
Calcif Tissue Int. 2022 Mar;110(3):334-340. doi: 10.1007/s00223-021-00918-0. Epub 2021 Dec 2.
9
Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
Curr Osteoporos Rep. 2016 Oct;14(5):178-86. doi: 10.1007/s11914-016-0317-0.

引用本文的文献

1
A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases.
Ther Adv Musculoskelet Dis. 2025 Aug 21;17:1759720X251369963. doi: 10.1177/1759720X251369963. eCollection 2025.
3
Pain in fibrous dysplasia: identifying nociceptive mechanisms in a preclinical model.
J Bone Miner Res. 2025 Jun 25;40(7):891-903. doi: 10.1093/jbmr/zjaf039.
4
Bone pain in fibrous dysplasia does not rely on aberrant sensory nerve sprouting or neuroma formation.
J Bone Miner Res. 2025 Jul 28;40(8):999-1014. doi: 10.1093/jbmr/zjaf066.
5
Pediatric Fibrous Dysplasia of the Skull Base: Update on Management and Treatment.
Brain Sci. 2024 Nov 29;14(12):1210. doi: 10.3390/brainsci14121210.
6
Fibrous dysplasia in children and its management.
Curr Opin Endocrinol Diabetes Obes. 2024 Feb 1;31(1):60-66. doi: 10.1097/MED.0000000000000847. Epub 2023 Nov 27.

本文引用的文献

2
Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone.
N Engl J Med. 2023 Feb 23;388(8):766-768. doi: 10.1056/NEJMc2214862.
3
Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
Int J Mol Sci. 2023 Jan 29;24(3):2550. doi: 10.3390/ijms24032550.
4
Microstructural white matter alterations associated with migraine headaches: a systematic review of diffusion tensor imaging studies.
Brain Imaging Behav. 2022 Oct;16(5):2375-2401. doi: 10.1007/s11682-022-00690-1. Epub 2022 Jun 16.
5
Effects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience.
Arch Endocrinol Metab. 2022 Apr 28;66(2):247-255. doi: 10.20945/2359-3997000000459. Epub 2022 Apr 11.
6
Case Report: The Imperfect Association Between Craniofacial Lesion Burden and Pain in Fibrous Dysplasia.
Front Neurol. 2022 Mar 16;13:855157. doi: 10.3389/fneur.2022.855157. eCollection 2022.
7
Neuropathic-like Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2258-e2266. doi: 10.1210/clinem/dgac120.
9
Long Bone Fractures in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History, and Risk Factors.
J Bone Miner Res. 2022 Feb;37(2):236-243. doi: 10.1002/jbmr.4463. Epub 2021 Nov 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验